EUVIMEDTutustu EUVIMEDiin
Open access

From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery

Benedette Cuffari

Journal of Medical Internet Research · 2026-05-29 · 28 · e101366-e101366

DOI: 10.2196/101366 ↗

At a glance

Journal article in Journal of Medical Internet Research, published online on 2026-05-29. Written by Benedette Cuffari. Major MEDLINE topics: Artificial Intelligence, Clinical Trials as Topic, Drug Discovery. Cited 1 times so far (Crossref). The full text is freely available in PubMed Central.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.

Subjects

MeSH terms (MEDLINE)

Artificial IntelligenceClinical Trials as TopicDrug DiscoveryHumansDrug Design

Author keywords

artificial intelligence in drug discoverycomputational drug discoveryde novo drug designgenerative chemistrymachine learning in drug design

Cite

APA

Cuffari, B. (2026). From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research, 28, e101366-e101366. https://doi.org/10.2196/101366

Vancouver

Cuffari B. From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of Medical Internet Research. 2026;28:e101366-e101366. doi:10.2196/101366

BibTeX
@article{Cuffari2026,
  author = {Cuffari, Benedette},
  title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e101366--e101366},
  doi = {10.2196/101366}
}
Start for free →